Johnson & Johnson subsidiary is set to expand its manufacturing capabilities in Ireland

By Catherine Sturman
Despite several controversies this year, Johnson & Johnson continue to dominate the healthcare market, with a multitude of generic, and pharmaceutic...

Despite several controversies this year, Johnson & Johnson continue to dominate the healthcare market, with a multitude of generic, and pharmaceutical products under its umbrella. Its growth has now seen the expansion of subsidiary Janssen Sciences’ Ringaskiddy facility in Cork harbour, where construction will begin at the end of October.

The construction works will create over 400 jobs, with 200 permanent upon completion. Despite the ongoing uncertainties with Brexit, Ireland remains an area of increased interests for businesses to grow or relocate their services to the country.

Set to take two years to complete, the €300 million expansion will see the facility increase over 200sq ft., therefore increasing its manufacturing capabilities to meet the growing demand for drugs in areas such as cancer and rheumatoid arthritis.

Related stories

Employment figures are set to rise by over 700 at Ringaskiddy and contribute fully to the Irish economy.

“The pharma industry makes a huge contribution to the Irish economy in terms of jobs and manufacturing exports and is one of our fastest-growing sectors,” commented Tánaiste and Minister for Business Frances Fitzgerald. “This expansion announced by Janssen is a strong commitment to our country.”

As well as a new facility, the subsidiary is also expanding its other buildings on site, from warehousing and logistics, to its administrative capacity in order to cater to the increased demands.

Share

Featured Articles

Hyfe AI uses acoustic AI in its digital cough monitoring

Hyfe uses acoustic AI in its digital cough monitoring. Dr. Joe Brew, Co-Founder & CEO of Hyfe AI, tells us more about coughing technology post-COVID-19

Siemens: smart finance to help medical technology growth

Penny Pinnock, Business Development Manager at Siemens Financial Services UK, discusses how adopting digital technology can support the healthcare sector

Healthcare Digital news roundup: prostate cancer & AI

This week in Healthcare Digital, we heard from experts in the sector: Trevor Dearing from Illumio, Avenda Health’s Brit Berry-Pusey & Vish Charan of Abbott

Lexica shares post-COVID-19 digital healthcare trends

Digital Healthcare

Medical devices expanding senior healthcare innovation

Medical Devices & Pharma

Abbott’s CRM medical devices can help cardiac arrhythmia

Medical Devices & Pharma